-
Jan 07, 2025Exploring Potential Routes For Biologics To Enter The BrainThis article delves into the various pathways through which biologics can cross the blood-brain barrier (BBB) to treat central nervous system (CNS) diseases. It highlights the r... -
Dec 30, 2024Exploring Animal Models For Atopic Dermatitis Drug EfficacyOverview of the construction and evaluation of animal models for studying atopic dermatitis (AD), discussing the disease's pathogenesis, model types, and therapeutic advancement...
-
Dec 27, 2024The Critical Role Of Animal Models in Human Disease ResearchLearn how Prisys Biotech pioneers the use of non-human primate (NHP) models to advance human disease research. Discover applications in drug discovery, disease mechanisms, and t... -
Dec 24, 2024Parkin Gene Deficiency Monkey Model Reveals New Mechanisms And Therapeutic Ta...New Breakthrough in Parkinson's Disease Research: Parkin Gene Deficiency Monkey Model Reveals New Mechanisms and Therapeutic Targets for Parkinson's Disease
-
Dec 20, 2024Nonclinical Drug Development Guide: Acute, Subacute, Subchronic, And Chronic ...Prisys Biotech specializing in nonhuman primate pharmacology and disease models. Our innovative approaches bridge the gap between preclinical research and clinical trials, provi... -
Dec 16, 2024Innovative Nasal-to-Brain (N2B) Drug Delivery: Bypassing The Blood-Brain BarrierDiscover the cutting-edge nasal-to-brain (N2B) drug delivery method. Learn how this non-invasive approach bypasses the blood-brain barrier to deliver therapeutics directly to th... -
Dec 09, 2024Opportunities And Challenges Of Mini Pigs As A Nonclinical Large Animal SpeciesExplore the growing role of miniature pigs in nonclinical research, their physiological similarities to humans, and the challenges and opportunities they present as an alternati...
-
Dec 03, 2024Drug Delivery Strategies For Brain DiseasesExplore the latest advancements in drug delivery strategies for brain diseases, including non-invasive, invasive, and emerging techniques, and their potential to overcome the bl...
-
Nov 26, 2024Ocular Toxicity Studies Of Eye Drops: Drug Exposure And Safety EvaluationExplore ocular toxicity studies for eye drops, focusing on drug exposure, transport mechanisms, and safety evaluations. Learn about the implications for anterior and posterior s...
-
Nov 11, 2024Comprehensive Preclinical Safety Evaluation Of Antibody-Drug Conjugates (ADCs...Prisys Biotech excels in preclinical ADC safety evaluations using non-human primate models, offering insights into ADC toxicokinetics, immunogenicity, tissue cross-reactivity, a...
-
Nov 08, 2024Pharmacokinetics Evaluation Of Antibody-Drug Conjugates (ADCs) in Non-Human P...Explore Prisys Biotech's advanced expertise in ADC pharmacokinetics evaluation using non-human primate models. Our CRO specializes in comprehensive PK analysis, stability studie...
-
Nov 06, 2024Pharmacodynamics Evaluation Of ADCsPrisys Biotech leads in ADC pharmacodynamics evaluation using advanced disease modeling in non-human primates. Our comprehensive assessment solutions span target affinity testin...
